Our publications keep professionals informed on the most important developments and issues in health security and biosecurity.
Find an article or report by keywords:
Center for Biosecurity of UPMC, February 15, 2013
The Center for Biosecurity of UPMC conducted this study to provide leaders in the US Department of Defense (DOD) with an expert assessment of the technical feasibility and strategic implications of next-generation monoclonal antibodies (mAbs) as medical countermeasures (MCMs) for DOD personnel. Our assessment includes identification of potentially appropriate DOD investments in mAb technologies.